Literature DB >> 2587595

Effect of chronic neonatal morphine and naloxone on sensorimotor and social development of young rats.

N Najam1, J Panksepp.   

Abstract

Chronic morphine treatment of newborn Long-Evans rat pups between 3-26 days of age (thrice daily starting with 0.5 mg/kg, increased daily by 0.5 mg/kg to 10 mg/kg) led to lags of 1 to 3 days in physical development (body weights and eye opening times) and motor coordination (catalepsy test, grasping, swimming). Chronic naloxone treatment (5 mg/kg administered thrice daily from day 3-26), in contrast, led to modest gains in development on a number of measures (body weights, vaginal opening). Morphine animals also lagged behind controls and naloxone-tested animals in social behaviors, such as homing and play. Chronic naloxone did not block or retard social development; in fact naloxone-treated animals exhibited more rapid acquisition of homing behavior than controls.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2587595     DOI: 10.1016/0091-3057(89)90383-3

Source DB:  PubMed          Journal:  Pharmacol Biochem Behav        ISSN: 0091-3057            Impact factor:   3.533


  4 in total

Review 1.  μ opioid receptor, social behaviour and autism spectrum disorder: reward matters.

Authors:  Lucie P Pellissier; Jorge Gandía; Thibaut Laboute; Jérôme A J Becker; Julie Le Merrer
Journal:  Br J Pharmacol       Date:  2017-05-04       Impact factor: 8.739

2.  Brain opioids and autism: an updated analysis of possible linkages.

Authors:  T L Sahley; J Panksepp
Journal:  J Autism Dev Disord       Date:  1987-06

Review 3.  Alcoholism: the role of different motivational systems.

Authors:  R O Pihl; J B Peterson
Journal:  J Psychiatry Neurosci       Date:  1995-11       Impact factor: 6.186

4.  Characterization of the intergenerational impact of in utero and postnatal oxycodone exposure.

Authors:  Katherine E Odegaard; Victoria L Schaal; Alexander R Clark; Sneh Koul; Austin Gowen; Jagadesan Sankarasubramani; Peng Xiao; Chittibabu Guda; Steven J Lisco; Sowmya V Yelamanchili; Gurudutt Pendyala
Journal:  Transl Psychiatry       Date:  2020-09-23       Impact factor: 6.222

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.